Vimarsana
Biggest News Aggregation in the World

Page 7 - Optune Lua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optune Lua Today - Breaking & Trending Today

NovoCure Limited (NASDAQ:NVCR) Receives $41.71 Consensus Target Price from Analysts - Vimarsana News

NovoCure Limited (NASDAQ:NVCR) Receives $41.71 Consensus Target Price from Analysts

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given an average rating of “Moderate Buy” by the eight brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have assigned a buy recommendation to […]

Source: wkrb13.com
NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by Analysts - Vimarsana News

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to […]

Analysts Set NovoCure Limited (NASDAQ:NVCR) PT at $41.71 - Vimarsana News

Analysts Set NovoCure Limited (NASDAQ:NVCR) PT at $41.71

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy […]

NovoCure Limited (NASDAQ:NVCR) Receives $41.71 Average PT from Analysts - Vimarsana News

NovoCure Limited (NASDAQ:NVCR) Receives $41.71 Average PT from Analysts

Shares of NovoCure Limited (NASDAQ:NVCR – Get Free Report) have received an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the […]

NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by Brokerages - Vimarsana News

NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by Brokerages

NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have issued a buy recommendation on the company. […]

Source: wkrb13.com